Come join others currently navigating treatment in our weekly Zoom Meetup! Register here: Tuesdays, 1pm ET.
Join us October 17 for our Webinar: Beyond Treatment: Getting the Follow Up Care You Need Register here.
Clinical Trial for Metastatic TNBC Now Recruiting
WC3
Member Posts: 658
CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer
Description
This phase I trial tests the safety, side effects, and best dose of CF33-hNIS-antiPDL1 in treating patients with triple negative breast cancer that has spread to other places in the body (metastatic). CF33-hNIS-antiPDL1 is an oncolytic virus. This is a virus that is designed to infect tumor cells and break them down.
0
Categories
Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.